Anti-Human CD28 Recombinant Antibody (HuTN228) (CAT#: TAB-069LC)
HuTN228 is a recombinant monoclonal antibody targeting CD28. It is a humanized antibody with potential applications in transplant rejection treatment. HuTN228 antibodies specifically recognize the CD28 antigen through interactions in the V-region. The IC50 value of HuTN228 is 0.5 g/ml.
Specific Inquiry
FC
Figure 1 The binding of FITC-labeled MuTN228 to P815/CD28′ cells in the presence of various amounts of competitor MuTN228 or HuTN228 antibody was analyzed in a flow cytometry competition experiment.
ELISA
Figure 2 ELISA competition assay.
The binding of biotinylated MuTN228 to sCD28-Fc in the presence of various amounts of competitor MuTN228 or HuTN228 antibody was analyzed in an ELISA competition experiment.
Figure 3 I¹²⁵ competition assay. The binding of ¹²⁵I labeled MuTN228 to P815/CD28+ cells in the presence of various amounts of competitor MuTN228 or HuTN228 antibody was analyzed in an ¹²⁵I labeled antibody competition experiment.
Specifications
- Host Species
- Human
- Derivation
- Humanized
- Type
- Humanized antibody
- Specificity
- Human
- Clone
- HuTN228
- Applications
- ELISA, FC
- Related Disease
- Transplant rejection
Applications
- Application Notes
- This antibody has been tested for use in Enzyme-linked Immunosorbent Assay and Flow Cytometry. Please see the Published Data for further information.
Target
Related Resources
Rheumatoid Arthritis
Systemic Lupus Erythematosus
Allograft Rejection
Autoimmune Thyroid Disease
Graft-versus-Host Disease
Maturity Onset Diabetes of the Young
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Clone HuTN228"
See other products for "CD28"
Select a product category from the dropdown menu below to view related products.
Please select product type
Humanized Antibody Products
IgG Antibody Products
Fab Antibody Products
Chimeric Antibody Products
Mouse Antibody Products
Human Antibody Products
Neutralizing Antibody Products
Blocking Antibody Products
Rabbit Monoclonal Antibody Products
Single Domain Antibody Products
ScFv Antibody Products
ADCC Enhanced Antibody Products
Agonistic Antibody Products
Antibody Magnetic Beads
Non-Human Primate (NHP) Antibody Products
Flow Cytometry (FC) related Products
ScFv-Fc Chimera Products
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-H46 | Humanized Anti-CD28 Recombinant Antibody (clone Lulizumab) | IP, IF, FuncS, FC, Neut, ELISA, IHC | Humanized V-kappa |
| TAB-064LC | Anti-Human CD28 Recombinant Antibody (TGN1412) | FC, Stim | Humanized antibody |
| TAB-065LC | Human Anti-CD28 Recombinant Antibody (TAB-065LC) | ELISA | Human IgG, κ |
| TAB-066LC | Human Anti-CD28 Recombinant Antibody (TAB-066LC) | FC, IF, ELISA | Human IgG1 |
| TAB-064LC-F(E) | Anti-Human CD28 Recombinant Antibody Fab Fragment (TGN1412) | FC | Humanized antibody |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for TAB-069LC. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
-1-1.png)
Application: ELISA
Application: WB, IHC, ELISA, FC
-1.jpg)
Application: ELISA, IHC, FC, IP, IF, Inhib
Application: ELISA, IHC, FC, IP, IF, Inhib
Application: ELISA, Cyt, PP, Inhib
Application: ELISA, FC, FuncS
Application: ELISA, Neut, FuncS
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
